Egypt’s medical device regulatory framework is governed by the Egyptian Drug Authority, EDA. Market entry requires a well-planned regulatory strategy, complete technical documentation, and lifecycle compliance planning, as registration requirements and timelines may vary depending on device classification, review pathway, and selected regulatory model.
EDA applies a classification approach broadly aligned with EU and U.S. FDA principles. In general, sterile medical devices and non-sterile Class IIa, IIb, and Class III devices require registration, while non-sterile Class I devices may be exempt. Reusable medical instruments may follow a listing route, although accessories may still require scientific review depending on their intended purpose and risk profile.
Medical device applications are submitted through EDA’s MEDevice platform. The dossier typically includes legal manufacturer documents, Free Sale Certificate or FDA certificate, CE certificate where applicable, ISO 13485 certificate, Declaration of Conformity, product composition, labeling, IFU, GMDN code, packaging, shelf life, sterilization details, test reports, pharmacovigilance commitment letter, and product samples.
Registration timelines should be planned conservatively. The normal review track may take approximately 12–18 months, while eligible fast-track applications may take around 6–9 months, depending on dossier completeness, reference approvals, sample review, and EDA deficiency requests.
Manufacturers may access the Egyptian market through a local legal entity, registered distributor, or Egypt Registration Holder. The ERH model is commonly used when manufacturers prefer to keep regulatory control separate from commercial distribution. After registration approval, additional procedures may still apply for import approvals, customs clearance, shipment release, and post-market compliance.
Recent EDA updates have further strengthened digital submission through MEDevice, structured dossier completeness checks, import approval procedures, customs release processes, annual import planning, and national vigilance expectations.
🔗For the detailed version, please visit our LinkedIn article
For regulatory and medical device registration support in Egypt, please contact:
📧 info@biomedista.com
🌐 www.biomedista.com
